Abstract: A thermal management system for an energy storage battery pack includes energy storage battery packs and temperature control sub-units. Each energy storage battery pack includes battery modules and a main housing used for accommodating the battery modules; the temperature control sub-units are mounted on the energy storage battery packs, respectively; each temperature control sub-unit includes a speed regulation fan used for dissipating heat for the energy storage battery pack, a temperature detector used for sensing a temperature of the battery modules and a pulse width modulation (PWM) controller; the speed regulation fan, the temperature detector and the PWM controller of one of the temperature control sub-units are in signal connection, the PWM controller is used for adjusting the duty ratio of the speed regulation fan according to the difference value between the temperature of the battery modules and a temperature threshold; and the temperature threshold is a preset value.

Abstract: A storage device includes a memory cell including a first layer, a second layer, and a memory layer between the first and second layers and can switch between states including a first state and a second state in which electrical resistance is higher, and a circuit executing a write process. The control circuit is configured to, in the process to switch the memory layer from the second to first state, alternately apply to the second layer a first voltage having positive polarity and a second voltage having negative polarity, an absolute value of the second voltage being larger than the first voltage, and in the process to switch the memory layer from the first to second state, alternately apply to the second layer a third voltage having negative polarity and a fourth voltage having positive polarity, an absolute value of the fourth voltage being larger than the third voltage.

Abstract: Provided is a small RNA, a composition comprising the small RNA, a method for using same and use of same. The small RNA or composition can inhibit the ability of any one or more of pathways or genes listed in Table 3, or decrease or down regulate the expression level of IL-1 beta, IL-6, and/or TNF-alpha in vitro or in vivo, or treat or prevent IL-1 beta, IL-6, and/or TNF-alpha related diseases and/or increase cell viability in a subject.

Abstract: The present invention discloses a Proteus mirabilis phage RDP-SA-16033. The host of the Proteus mirabilis phage is Proteus mirabilis S5. The phage may form a plaque having a diameter of 4-6 mm on a double-layer plate. When observed through an electron microscope, the phage has a head in polyhedral cubic symmetry, is coated by nucleic acid, has a diameter of about 70 nm, has a tail of about 150 nm long, has a tail sheath, has a neck connected to the head and the tail, and belongs to tailed virales myovirus division. The present invention further provides a production process of the phage. After centrifugation of value-added liquid, a titer of the phage is increased by membrane concentration, and then residual host and other infectious microbes in value-added are effectively removed by a ceramic membrane and a 0.22 ?m polyethersulfone filter membrane. Meanwhile, the phage is reserved to the utmost extent.

Abstract: According to one embodiment, a memory element includes a first conductive layer, a second conductive layer, and a first layer. The first conductive layer includes an ion source. The first layer includes a first element and is provided between the first conductive layer and the second conductive layer. An electronegativity of the first element is greater than 2. The first layer includes a first region and a second region. The first region includes the first element. The second region is provided between the first region and the second conductive layer. The second region does not include the first element, or the second region includes the first element, and a concentration of the first element in the first region is higher than a concentration of the first element in the second region.

Abstract: The presently disclosed subject matter is directed to an RGD peptide and penetrating peptide R8 co-modified ergosterol and cisplatin active drug-loading liposome that is prepared by means of the incubation of an ergosterol and cisplatin active drug-loading liposome, RGD cyclic peptide, and penetrating peptide R8 in a water bath. The ergosterol and cisplatin active drug-loading liposome is prepared from an ergosterol liposome and a cisplatin solution serving as the raw materials. The ergosterol liposome is prepared from 8 wt % to 15 wt % ergosterol and 85 wt % to 92 wt % liposomes, and the liposomes consist of lecithin and cholesterol.

Abstract: According to one embodiment, a memory element includes a first conductive layer, a second conductive layer, and a first layer. The first conductive layer includes an ion source. The first layer includes a first element and is provided between the first conductive layer and the second conductive layer. An electronegativity of the first element is greater than 2. The first layer includes a first region and a second region. The first region includes the first element. The second region is provided between the first region and the second conductive layer. The second region does not include the first element, or the second region includes the first element, and a concentration of the first element in the first region is higher than a concentration of the first element in the second region.